Drug
Temozolomide
Temozolomide: highest development phase Phase 2, developed by Bayer, GlaxoSmithKline. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Bayer, GlaxoSmithKline
Trials
| Drug | Phase | Indication |
|---|---|---|
| Temozolomide NCT02599090 | Phase 2 | Glioblastoma |
| temozolomide NCT01465659 | Phase 1/2 | Pancreatic Alpha Cell Carcinoma |
Latest
No recent events.
Follow Temozolomide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.